Showing 1021-1030 of 2993 results for "".
NeuroAdvocacy: Why Lobbying Matters
https://practicalneurology.com/columns/practice-management/neuroadvocacy-why-lobbying-matters/30328/Advocating for patients and the specialty is a powerful way for physicians to make their voices heard.Precision Medicine: How Advancements in Imaging, Delivery, and Patient Comfort are Increasing the Relevance of Deep Brain Stimulation
https://practicalneurology.com/diseases-diagnoses/imaging-testing/precision-medicine-how-advancements-in-imaging-delivery-and-patient-comfort-are-increasing-the-relevance-of-deep-brain-stimulation/30382/PFO in Cryptogenic Stroke Patients
https://practicalneurology.com/diseases-diagnoses/stroke/pfo-in-cryptogenic--stroke-patients/30817/The lead investigator from the REDUCE trial discusses his perspective on how these patients should be approached.A Diagnosis of Exclusion: Keys to Consider on the Diagnostic Accuracy of Alzheimer's Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-diagnosis-of-exclusion-keys-to-consider-on-the-diagnostic-accuracy-of-alzheimers-disease/30501/New research suggests that the diagnosis of Alzheimer's Disease is not as simple as previously thought.Cryptogenic Stroke & Atrial Fibrillation: Establishing the Link Through Team Approaches to Care
https://practicalneurology.com/diseases-diagnoses/stroke/cryptogenic-stroke--atrial-fibrillation-establishing-the-link-through-team-approaches-to-care/30393/Implementing a Cryptogenic Stroke Pathway may help reduce recurrent strokes and improve outcomes for stroke patients.Comprehensive Stroke Certification What Does Does it Take?
https://practicalneurology.com/diseases-diagnoses/stroke/comprehensive-stroke-certification-what-does-does-it-take/30704/The Ochsner Medical Center ExperienceMedical Marijuana: Composition, Neurological Benefits, And Adverse Events
https://practicalneurology.com/diseases-diagnoses/headache-pain/medical-marijuana-composition-neurological-benefits-and-adverse-events/30512/Exploring the potential benefits of medical marijuana in neurology and future directions in care.Continuous Movement of the Toes
https://practicalneurology.com/diseases-diagnoses/movement-disorders/continuous-movement-of-the-toes/31107/In this case, we present a 26-year-old African American male with an 18-month history of constant involuntary alternating dorsiflexion-plantar flexion movements of his left toes, especially the big toe. With manual interference and conscious attention, he could eliminate the movement. He had dull pa- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c